###begin article-title 0
Identification of Novel Single Nucleotide Polymorphisms in Inflammatory Genes as Risk Factors Associated with Trachomatous Trichiasis
###end article-title 0
###begin p 1
Conceived and designed the experiments: DD. Analyzed the data: BA TAS DD. Contributed reagents/materials/analysis tools: RPK BS HKA LS HE DD. Wrote the paper: BA TAS DD. Acquisition of data: DD RPK BS HKA. Obtained funding: DD. Supervised study: DD. Critical revision of the manuscript: HE.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 128 149 128 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia trachomatis</italic>
###xml 128 149 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Trachoma is the leading preventable cause of global blindness. A balanced Th1/Th2/Th3 immune response is critical for resolving Chlamydia trachomatis infection, the primary cause of trachoma. Despite control programs that include mass antibiotic treatment, reinfection and recurrence of trachoma are common after treatment cessation. Furthermore, a subset of infected individuals develop inflammation and are at greater risk for developing the severe sequela of trachoma known as trachomatous trichiasis (TT). While there are a number of environmental and behavioral risk factors for trachoma, genetic factors that influence inflammation and TT risk remain ill defined.
###end p 3
###begin title 4
Methodology/Findings
###end title 4
###begin p 5
###xml 782 783 782 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
We identified single nucleotide polymorphisms (SNP) in 36 candidate inflammatory genes and interactions among these SNPs that likely play a role in the overall risk for TT. We conducted a case control study of 538 individuals of Tharu ethnicity residing in an endemic region of Nepal. Trachoma was graded according to World Health Organization guidelines. A linear array was used to genotype 51 biallelic SNPs in the 36 genes. Analyses were performed using logic regression modeling, which controls for multiple comparisons. We present, to our knowledge, the first significant association of TNFA (-308GA), LTA (252A), VCAM1 (-1594TC), and IL9 (T113M) polymorphisms, synergistic SNPs and risk of TT. TT risk decreased 5 times [odds ratio = 0.2 (95% confidence interval 0.11.-0.33), p = 0.001] with the combination of TNFA (-308A), LTA (252A), VCAM1 (-1594C), SCYA 11 (23T) minor allele, and the combination of TNFA (-308A), IL9 (113M), IL1B (5'UTR-T), and VCAM1 (-1594C). However, TT risk increased 13.5 times [odds ratio = 13.5 (95% confidence interval 3.3-22), p = 0.001] with the combination of TNFA (-308G), VDR (intron G), IL4R (50V), and ICAM1 (56M) minor allele.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
Evaluating genetic risk factors for trachoma will advance our understanding of disease pathogenesis, and should be considered in the context of designing global control programs.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 47 68 47 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia trachomatis</italic>
###xml 175 178 175 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Dean1">[1]</xref>
###xml 275 278 275 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Resnikoff1">[2]</xref>
###xml 518 521 516 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-West1">[3]</xref>
###xml 638 641 636 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-West1">[3]</xref>
###xml 643 646 641 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Dean2">[4]</xref>
###xml 47 68 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Trachoma is a chronic ocular disease caused by Chlamydia trachomatis, although other chlamydial species have recently been implicated in trachomatous inflammation and disease [1]. Trachoma remains the primary preventable cause of visual impairment and blindness in the world [2]. Repeated and/or persistent ocular infections and inflammation can result in subsequent conjunctival scarring and fibrosis, leading to entropion (distorted eyelid) and trichiasis (TT;>/=one in-turned eyelash touching the globe of the eye) [3]. TT represents an important threat to vision because of the development of corneal abrasions and subsequent opacity [3], [4].
###end p 9
###begin p 10
###xml 190 193 190 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-WHO1">[5]</xref>
###xml 336 339 336 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Atik1">[6]</xref>
###xml 340 343 340 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-West2">[9]</xref>
The World Health Organization (WHO) developed the SAFE strategy [Surgery, Antibiotic treatment, Facial cleanliness, Environmental improvement] to eliminate blinding trachoma by the year 202 [5]. However, mass or targeted antibiotics has resulted in the recurrence of trachoma and infection after treatment cessation in multiple studies [6]-[9]. Consequently, there has been a continued focus on understanding host immune responses for each grade of trachomatous disease along with chlamydial infection to provide the knowledge to enhance control programs and vaccine development, and assess vaccine efficacy once one becomes available.
###end p 10
###begin p 11
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Holmgren1">[10]</xref>
###xml 789 793 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Bobo1">[11]</xref>
###xml 794 798 784 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Faal1">[13]</xref>
###xml 1196 1200 1186 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Skwor1">[14]</xref>
###xml 1485 1499 1472 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. trachomatis</italic>
###xml 1485 1499 <span type="species:ncbi:813">C. trachomatis</span>
Humoral and cell mediated immune responses are considered essential in both the clearance of chlamydial infection and in the immunopathogenesis of trachomatous disease, although the pathogenic mechanisms remain unclear. Cell mediated immunity is primarily controlled by cytokines at the local mucosal microenvironment [10]. The contribution and presence of a particular cytokine may vary according to the stage of infection or grade of trachoma. Some studies have evaluated cytokine mRNA gene expression in trachoma and found that transforming growth factor beta (TGF-beta) and the pro-inflammatory cytokines, interleukin-1 beta (IL-1beta) and tumor necrosis factor alpha (TNF-alpha), were significantly elevated in trachomatous follicular inflammation (TF) and trachomatous scarring (TS) [11]-[13]. We recently expanded on the characterization of cytokines and also identified chemokines involved in the immunopathology of different grades of trachoma using a more robust approach that involved conjunctival mucosal protein quantitation. Our findings highlight the importance of Th1 cytokines in protection against TS as evidenced by decreased protein levels for IL-12p40 compared with controls [14]. Additionally, we identified involvement of the Th2 cytokines IL-4 and IL-13 in eliciting protective immunity, and IL-10 and IL-15 as possible Th3/Tr1 cytokines and risk factors for TS. IL-1beta was also a strong risk factor for scarring while its antagonist, IL-1Ra, was protective. C. trachomatis infection was significantly associated with elevated proinflammatory TNF-alpha and IL-6 cytokines, the Th3/Tr1 IL-10 and IL-15 cytokines, and the Th1-associated chemokines MIP-1beta and RANTES in the presence of trachomatous disease, suggesting an added microbial influence on trachoma pathogenesis.
###end p 11
###begin p 12
###xml 371 374 371 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-West1">[3]</xref>
###xml 451 454 451 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-West1">[3]</xref>
###xml 456 460 456 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Muoz1">[15]</xref>
To further characterize the host immune response, it will be necessary to evaluate host genetic susceptibility to the development of trichiasis. This is particularly important because some individuals in trachoma endemic areas develop severe inflammation with each infection while others in the same community do not, despite similar environmental and ethnic backgrounds [3]. Furthermore, the former are significantly more likely to develop TS and TT [3], [15].
###end p 12
###begin p 13
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Conway1">[16]</xref>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Natividad2">[20]</xref>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 237 238 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 292 293 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 311 312 311 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Conway1">[16]</xref>
###xml 398 400 398 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GA</italic>
###xml 435 437 435 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
###xml 515 517 515 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</italic>
###xml 568 572 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Conway1">[16]</xref>
###xml 574 578 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-MozzatoChamay1">[17]</xref>
###xml 580 584 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Natividad1">[19]</xref>
###xml 586 590 586 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Natividad2">[20]</xref>
###xml 609 612 609 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G&gt;T</italic>
###xml 626 629 626 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G&gt;A</italic>
###xml 636 639 636 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G&gt;A</italic>
###xml 717 720 717 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&gt;G</italic>
###xml 727 730 727 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C&gt;T</italic>
###xml 737 740 737 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C&gt;T</italic>
###xml 755 758 755 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C&gt;T</italic>
###xml 766 769 766 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T&gt;C</italic>
###xml 777 780 777 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C&gt;T</italic>
###xml 794 797 794 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T&gt;C</italic>
###xml 815 825 815 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T&gt;C or A&gt;G</italic>
###xml 832 835 832 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C&gt;T</italic>
###xml 842 845 842 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&gt;C</italic>
###xml 849 852 849 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G&gt;T</italic>
###xml 888 892 888 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Conway1">[16]</xref>
###xml 893 897 893 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Natividad2">[20]</xref>
###xml 971 975 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Natividad1">[19]</xref>
###xml 983 987 983 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-MozzatoChamay1">[17]</xref>
###xml 1237 1238 1237 1238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1258 1262 1258 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Natividad3">[21]</xref>
There have been some studies evaluating the association between single nucleotide polymorphisms (SNPs) among inflammatory genes and trachomatous disease [16]-[20]. In Gambia, Th1/Th2/Th3 gene SNPs, including IFNG (+3234 C), IL-10 (+5009 G, -1082 G only in the Mandinka ethnic group, and -3575A), and TNFA (-308 A), were found to be associated with a higher odds of having TS [16], while TNFA (-308 GA) and lymphotoxin alpha [LTA, +252 GG, and inhibitor of kappa light chain gene enhancer in B-cells-like (IKBL, -63 TT) SNPs were significantly associated with TS or TT [16], [17], [19], [20]. SNPs in LTA (+77 G>T), TNFA (-238 G>A, -376 G>A), inhibitor of kappa light chain gene enhancer in B-cells, alpha (IKBA, -881 A>G, -826 C>T, -297 C>T), IFNG (-1616 C>T, +2200 T>C, +5612 C>T), IL-4 (-590 T>C) and IL10 (-1082 T>C or A>G, -819 C>T, -592 A>C or G>T) were not associated with TS or TT [16]-[20]. For the IL10 (-1082) polymorphism, the literature is contradictory (T>C [19] or A>G [17]). More recently, researchers found that heterozygosity for the Q279R polymorphism in matrix metalloproteinase 9 (MMP-9), which plays a role in tissue remodeling, was associated with lower risk for scarring trachoma compared to homozygosity for the "A" allele (i.e.Q279) [21]. These findings suggest a role for SNPs in the pathogenesis of trachoma. However, all of these studies were conducted in Gambia, and only two of these used TT as the outcome. Similar studies need to be replicated among trachoma endemic populations in other countries. Additionally, there are a plethora of inflammatory genes and SNPs that remain to be characterized in association with trachoma.
###end p 13
###begin p 14
The purpose of the present study was to expand on previous SNP research and determine whether subjects with TT were more likely to have particular SNPs compared to subjects without any evidence for trachoma. We screened 51 SNPs derived from 36 biologically plausible candidate genes encoding proteins in inflammatory pathways to identify genetic markers that may assist in elucidating the pathogenesis of trachoma in a Nepali population. To our knowledge, this is the first study to examine such a large array of inflammatory SNP markers in association with trachomatous disease.
###end p 14
###begin title 15
Materials and Methods
###end title 15
###begin title 16
Study Population and Trachoma Grading
###end title 16
###begin p 17
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Thylefors1">[22]</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Zhang1">[23]</xref>
###xml 105 113 <span type="species:ncbi:9606">Children</span>
###xml 359 371 <span type="species:ncbi:9606">participants</span>
The study and written informed consent for the study were approved by the Institutional Review Boards of Children's Hospital and Research Center at Oakland, CA, and the Nepal Netra Jhoti Sang, Kathmandu, Nepal, according to the Convention of Helsinki. A survey was conducted in a trachoma endemic region of Kapilvastu District, Lumbini Zone, Nepal. All study participants were of the Tharu ethnic group. Trachoma grading was performed using the modified grading scale according to WHO guidelines as described previously [22], [23]. Briefly, subjects with <5 follicles on the lower 2/3 of the upper tarsus were defined as having no trachoma. Trachomatous inflammation, follicular (TF) was defined as five or more follicles in the upper tarsus, trachomatous inflammation, intense (TI) as intense inflammatory thickening of upper tarsal conjunctiva with indistinct deep tarsal vessels, trachomatous scarring (TS) as the presence of scarring in the upper tarsus, and trachomatous trichiasis (TT) as at least one in-turned eyelash rubbing the eyeball or history of epilation (removal of in-turned eyelashes). After obtaining informed consent, research staff enumerated and clinically examined all household members in two villages in the district.
###end p 17
###begin p 18
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Dean1">[1]</xref>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Zhang1">[23]</xref>
###xml 465 479 465 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. trachomatis</italic>
###xml 465 479 <span type="species:ncbi:813">C. trachomatis</span>
###xml 701 709 <span type="species:ncbi:9606">Children</span>
Whole blood samples collected in ethylenediaminetetraacetic acid (EDTA) containing tubes and conjunctival swabs were obtained from all villagers as previously described [1], [23]. Briefly, the upper tarsal conjunctivae of both eyes were swabbed with a Dacron swab (American Scientific Products, McGraw Park, IL). Swabs were placed in collection media (M4-RT; Micro-Test, Lilburn, GA). A new set of gloves was used for each subject to prevent cross-contamination of C. trachomatis. All the samples were dated and coded with a unique ID number to maintain confidentiality and to process samples in a masked fashion. The samples were immediately placed in liquid nitrogen transport tanks for transfer to Children's Hospital Oakland Research Institute where the samples were then stored at -80degreesC until processed.
###end p 18
###begin title 19
###xml 13 34 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Detection of Chlamydia trachomatis
###end title 19
###begin p 20
###xml 78 92 78 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. trachomatis</italic>
###xml 198 201 198 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Dean1">[1]</xref>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Skwor1">[14]</xref>
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Zhang1">[23]</xref>
###xml 455 461 455 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">450 nm</sub>
###xml 492 498 490 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">450 nm</sub>
###xml 534 540 530 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">450 nm</sub>
###xml 712 715 708 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Dean1">[1]</xref>
###xml 717 721 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Zhang1">[23]</xref>
###xml 812 816 808 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ompA</italic>
###xml 78 92 <span type="species:ncbi:813">C. trachomatis</span>
The Amplicor-PCR assay (Roche Diagnostics, Branchburg, NJ) was used to detect C. trachomatis for each conjunctival sample according to the manufacturer's instructions and as we described previously [1], [14], [23]. Of note is that gloves were used in between subjects to prevent cross-contamination of the collected samples. Optical density (OD) was measured at 450 nm using an automated microwell plate reader. Samples were defined as positive with an OD450 nm of >/=0.8, negative with an OD450 nm of </=0.2, and equivocal with an OD450 nm between 0.2 to 0.8. All equivocal samples were reevaluated by an in-house validation PCR test to further assess the presence or absence of chlamydiae as we have described [1], [23]. Briefly, DNA isolated from conjunctival swabs was amplified using primers that flank the ompA gene. PCR products of the same molecular weight size as the PCR positive control were considered positive as long as the negative control was negative.
###end p 20
###begin title 21
Extraction of Genomic DNA
###end title 21
###begin p 22
###xml 494 500 485 491 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">260 nm</sub>
Genomic DNA was extracted from whole blood using Genovision GenoMtrade mark (GenoVision Inc., West Chester, PA), according to manufacturer's instructions. The principle of DNA isolation and purification by GenoVision technology is that DNA binds to the glass surface of magnetic beads in the presence of a chaotropic solution. Cell lysis is followed by binding of DNA to magnetic beads, washing and elution of the DNA. The concentration of the DNA was determined using a spectrophotometer at OD260 nm.
###end p 22
###begin title 23
Linear array for SNP detection
###end title 23
###begin p 24
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Barcellos1">[24]</xref>
###xml 913 921 909 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003600-g001">Figure 1</xref>
We used an immobilized probe linear array assay developed by Roche Molecular Systems (Alameda, CA) to genotype 51 biallelic SNPs in 36 genes associated with inflammation as previously described by Barcellos et al.[24], although in the referenced study, only 34 genes were used. The selection of SNPs was based on publicly available databases that included Caucasian and Chinese data. Briefly, 25 ng of genomic DNA from each sample was amplified by multiplex PCR using biotinylated primers for all 51-gene polymorphisms. Two probes were designed for each biallelic site to detect and distinguish between variant sequences. The PCR product was denaturated with 10 microl Amplicor base streptavidin-HRP and a colorless soluble substrate, which is converted into a blue precipitate. Bands on the developed arrays were aligned to a guide to identify the respective allele, and the arrays were scanned into a computer (Figure 1). SNP interpretations were made independently by two individuals masked as to all subject data.
###end p 24
###begin title 25
Representative linear array results for Strip 1 for samples from six Tharu individuals from a trachoma endemic area of Nepal.
###end title 25
###begin p 26
###xml 46 53 46 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">methods</xref>
Bands represent wild type and SNP probes (see methods). Strip 1 contains 25 SNPs. Strip 2 contains 26 SNPs (not shown). To the left and right of the probes are the names of the alleles; horizontal blur lines represent amplified alleles.
###end p 26
###begin title 27
Data Analysis
###end title 27
###begin p 28
###xml 286 300 286 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. trachomatis</italic>
###xml 286 300 <span type="species:ncbi:813">C. trachomatis</span>
Allele and genotype frequencies were compared for cases (TT) vs. controls (no evidence for TF, TI, TS or TT) by chi-square test. Hardy-Weinberg equilibrium (HWE) was tested for each SNP. We performed simple and multiple logistic regression analysis; age, sex, having TF, TI, TS, TT and C. trachomatis infection status were covariates included in multiple logistic regression. Finally, we performed logic regression to analyze interactions among multiple SNPs.
###end p 28
###begin p 29
###xml 61 65 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Ruczinski1">[25]</xref>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Ruczinski1">[25]</xref>
Logic regression was used to identify gene-gene interactions [25]. Correction for multiple comparisons is not considered necessary in logic regression since the multi-step model selection is very precise and thereby accounts for multiple comparisons [25]. Instead of cross-product terms that are used in logistic regression, logic builds Boolean expressions in the form of "and/or" trees (L) to identify gene interactions. A simulated annealing algorithm is used to predict logic trees. The annealing algorithm works by starting from a particular state and then selecting a move to a new state. The score of the new state is compared with the score of the old state. If the score of the new state is better than the score of the old state, the move is accepted. We chose to use the simulated annealing algorithm because it is a robust technique for nonlinear models even though it is computationally very demanding.
###end p 29
###begin p 30
We used logic regression within the context of logistic regression. In this study, the outcome was binary [subjects having TT (cases) or no evidence for any trachoma grade (controls)]. Deviance was used as the scoring function. We used the 10-fold cross-validation test, comparing the best model to models of different sizes. In addition, we used randomization tests to determine optimal model size. In order to carry out a null-model test for signal in the data, an initial "best scoring" model, allowing up to two trees and eight leaves (the default maximum tree size provided by the function "logreg") was obtained. The score of this "best model" was then compared to the distribution of scores obtained by repeatedly permuting the outcome and refitting the data. The proportion of scores from the permuted data that are better than the best score of the original data is reported as an exact p-value. We used the more conservative p-value of less than 0.001 as a cut-off for statistical significance in the logic analysis.
###end p 30
###begin title 31
Results
###end title 31
###begin title 32
Clinical and Demographic Characteristics of Study Population
###end title 32
###begin p 33
###xml 155 162 155 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003600-t001">Table 1</xref>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 299 300 299 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 357 360 357 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-West1">[3]</xref>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Ngondi1">[26]</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Khandekar1">[27]</xref>
###xml 392 406 392 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. trachomatis</italic>
###xml 625 629 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Zhang1">[23]</xref>
###xml 631 635 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Melese1">[28]</xref>
###xml 637 641 637 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Burton3">[29]</xref>
###xml 672 675 672 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Atik1">[6]</xref>
###xml 677 681 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Miller1">[30]</xref>
###xml 682 686 682 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-West3">[32]</xref>
###xml 392 406 <span type="species:ncbi:813">C. trachomatis</span>
The study population comprised individuals from a trachoma endemic region of Southwestern Nepal. Characteristics of the study population are summarized in Table 1. Having TT was significantly associated with older age [O.R. = 1.07 (1.05-1.09), p-value = 0.001] and being female [O.R. = 3.1 (2-4.8), p-value = 0.001], which is consistent with the literature [3], [26], [27]. The prevalence of C. trachomatis infection was 11.3% (22/194) for controls, 48 (27.6%) for those with TF and/or intense trachomatous inflammation (TI), and 16.5% (21/127) for TT cases. Other studies have also found high infection rates among TT cases [23], [28], [29] and high rates among controls [6], [30]-[32].
###end p 33
###begin title 34
Characteristics of Study Population.
###end title 34
###begin p 35
TT includes cases with or without TF and/or TI.
###end p 35
###begin p 36
###xml 121 135 117 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. trachomatis</italic>
###xml 121 135 <span type="species:ncbi:813">C. trachomatis</span>
Statistically significant difference at alpha level = 0.001 by two sampled t-test (age) or Pearson chi-square test (sex, C. trachomatis-positive).
###end p 36
###begin p 37
###xml 40 54 40 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. trachomatis</italic>
###xml 40 54 <span type="species:ncbi:813">C. trachomatis</span>
Amplicor PCR test was used to determine C. trachomatis infection status and was available for 194 controls, 174 TF/TI and 127 TT cases.
###end p 37
###begin title 38
Genomic frequencies of 51 inflammatory SNPs among TT cases vs. controls
###end title 38
###begin p 39
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-King1">[33]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Bowman1">[35]</xref>
Because all the cases and controls in the study were of the Tharu ethnic group, we assumed that population admixture would not be a confounder in the analyses. Also, because subjects under age 20 years can have TS and TT [33]-[35], we felt it was reasonable to include them in our study.
###end p 39
###begin p 40
###xml 52 60 52 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003600-g001">Figure 1</xref>
###xml 312 319 312 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003600-t002">Table 2</xref>
###xml 560 563 560 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G&gt;A</italic>
###xml 575 578 575 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G&gt;A</italic>
###xml 592 595 592 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C&gt;T</italic>
###xml 622 625 622 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C&gt;G</italic>
###xml 641 644 641 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T&gt;C</italic>
###xml 657 660 657 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C&gt;T</italic>
###xml 750 753 750 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C&gt;T</italic>
###xml 803 810 803 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003600-t003">Table 3</xref>
An example of the linear array results are shown in Figure 1; all samples yielded appropriate readable bands in the array, suggesting a lack of inhibitors in the PCR and downstream hybridization. Single allele frequencies by TT status were compared with controls for the 51 candidate SNPs, and are summarized in Table 2. We defined major allele as the first allele that appeared in the inflammatory panel, and minor allele as the second allele that appeared in the panel. Genotype frequencies differed significantly by TT compared with controls for TNFA (-308 G>A), LTA (252 G>A), IL1A (-889 C>T), IL1B (F105F), IL6 (-174 C>G), VCAM1 (-1594 T>C), IL4 (-589 C>T), IL4R (Q576R, and I50V), IL9 (T113M), CCR3 (P39L), ADRB2 (Q27E, and T164I), CTLA4 (-318 C>T), NOS2A (D346D), and NOS3 (E298D) polymorphisms (Table 3). All observed genotype frequencies between TT cases and controls in our study were in HWE.
###end p 40
###begin title 41
Major Allele Frequencies among 51 SNPs in 36 Inflammatory Genes for Trachomatous Trichiasis (TT) Cases and Controls.
###end title 41
###begin p 42
The first allele that appeared in the linear array inflammatory panel was referred to as the major allele; the second allele in the panel was referred to as the minor.
###end p 42
###begin p 43
.
###end p 43
###begin p 44
Total number of controls was 230 for ADRB2 (T164I), ICAM1 (G241R), CCR3 (P39L), CCR5 (WTDEL32), TCF7 (P19T); 231 for IL1B (-1418); total number of TT cases was 134 for TCF7 (UAS).
###end p 44
###begin title 45
Genotype Distribution by TT Status Based on Univariate Analysis.
###end title 45
###begin p 46
Total number of controls were 230 for ADRB2(T164I), CCR3(P39L), total number of TT cases were same as all (n = 135).
###end p 46
###begin p 47
###xml 75 89 75 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. trachomatis</italic>
###xml 194 201 194 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003600-t004">Table 4</xref>
###xml 236 239 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G&gt;A</italic>
###xml 256 259 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G&gt;A</italic>
###xml 297 300 297 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T&gt;C</italic>
###xml 430 433 430 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G&gt;A</italic>
###xml 582 583 582 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 695 696 695 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 787 790 787 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G&gt;A</italic>
###xml 75 89 <span type="species:ncbi:813">C. trachomatis</span>
After multivariate logistic analysis controlling for age, sex, TF, TI, and C. trachomatis infection status, only certain SNPs remained significantly associated with TT compared to the controls (Table 4). The pro-inflammatory TNFA (-308 G>A), and LTA (+252 G>A), the adhesion molecule VCAM1 (-1594 T>C), and the Th2 cytokine IL-9 (T113M) gene SNPs were significantly associated with TT cases compared with controls. For TNFA (-308 G>A), heterozygosity was associated with significantly decreased odds of TT compared with homozygosity for the major genotype [O.R. = 0.45 (0.25-0.81), p = 0.008]. Similarly, the odds of TT were less in homozygous minor allele individuals [O.R. = 0.25 (0.09-0.63), p = 0.004] compared with individuals with homozygous major allele genotype for the LTA (252 G>A) polymorphism.
###end p 47
###begin title 48
Multivariate Analysis of Inflammatory Gene SNPs Associated with TT Cases Compared with Controls.
###end title 48
###begin p 49
###xml 83 97 83 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. trachomatis</italic>
###xml 83 97 <span type="species:ncbi:813">C. trachomatis</span>
Covariates included in multivariable logistic regression were age, sex, TF/TI, and C. trachomatis infection status for predicting O.R. s with 95% CI.
###end p 49
###begin p 50
###xml 94 97 94 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T&gt;C</italic>
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 268 275 268 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003600-t004">Table 4</xref>
Among the SNPs in genes encoding adhesion molecules, TT was associated only with VCAM1 (-1594 T>C). The odds ratio for heterozygous individuals was significantly less [O.R. = 0.47 (0.25-0.86), p = 0.015] than for individuals with the homozygous major allele genotype (Table 4).
###end p 50
###begin p 51
###xml 221 228 221 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003600-t004">Table 4</xref>
###xml 255 256 255 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Among the cytokines associated with T helper lymphocyte polarity, we found that the heterozygous IL9 (T113M) genotype was a likely protective factor against TT compared with individuals homozygous for the major genotype (Table 4, O.R. = 0.25 (0.10-0.64), p = 0.004).
###end p 51
###begin p 52
###xml 234 243 234 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003600.s001">Tables S1</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003600.s002">S2</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003600.s003">S3</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003600.s004">S4</xref>
Although we controlled for age and sex in the analyses as described above, we also stratified subjects by age and sex, controlling for infection, and reanalyzed the data. We found similarly statistically significant results as above (Tables S1, S2, S3, S4).
###end p 52
###begin title 53
Logic regression analysis of interacting SNPs
###end title 53
###begin p 54
###xml 66 74 66 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003600-g002">Figure 2</xref>
###xml 300 304 300 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1.6</sup>
###xml 414 415 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 443 444 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 547 548 547 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 608 609 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 641 642 641 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 712 713 712 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 723 732 723 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003600-g002">Figure 2A</xref>
###xml 911 912 911 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 943 944 943 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 1024 1033 1024 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003600-g002">Figure 2B</xref>
We further investigated the potential impact of interacting SNPs. Figure 2 shows the logic trees (L) of interacting SNPs that are associated with TT. The logic modeling resulted in Logit P (TT = 1| risk inflammatory SNPs) = 0.3-1.6*L1+2.6*L2. According to logic modeling, TT risk decreased 5 times (e-1.6 = 0.2) by the tree (L1) specifying SNP combinations, namely, individuals with a combination of (1) TNFA(-308 A) minor allele and LTA (252 A) minor allele and either VCAM1 (-1594C) minor allele or SCYA 11 (23T) minor allele, or (2) TNFA (-308 A) minor allele and IL-9 (113M) minor allele and IL1B (5'UTR T) minor allele and VCAM1 (-1594 C) minor allele [odds ratio = 0.2 (95% confidence interval 0.11-0.33), p = 0.001, Figure 2A]. In the second tree (L2), TT risk increased 13.5 times [odds ratio = 13.5 (95% confidence interval 3.3-22), p = 0.001] for individuals demonstrating a combination of TNFA (-308 G) major allele and VDR (intron G) minor allele, and either IL4R (50V) minor allele or ICAM1 (56M) minor allele (Figure 2B).
###end p 54
###begin title 55
Logic Tree Models for interacting SNPs associated with TT.
###end title 55
###begin p 56
###xml 41 42 41 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 70 71 70 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 111 112 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 176 177 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 272 273 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 331 332 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 363 364 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 528 529 528 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 559 560 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 595 596 595 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 665 666 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 734 735 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 769 770 769 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 809 810 809 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 843 844 843 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
TOP, L1 is a combination of (1)TNFA(-308 A) minor allele and LTA (252 A) minor allele and either VCAM-1 (-1594 C) minor allele or SCYA 11 (23T) minor allele, or (2) TNFA (-308 A) minor allele and IL-9 (113M) minor allele and IL-1B (5'UTR T) minor allele and VCAM-1 (-1594 C) minor allele. BOTTOM, L2 is a combination of TNFA (-308 G) major allele and VDR (intron G) minor allele, and either IL-4R (50V) minor allele or ICAM-1 (56M) minor allele: Logit P (TT = 1| risk inflammatory SNPs) = 0.3-1.6*L1+2.6*L2. L1 = ((((TNFA (-308 A) minor allele) and (LTA (252 A) minor allele)) and ((VCAM1(-1594 C) minor allele) and (SCYA 11 (A23T) minor allele))) OR (((TNFA (-308 A) minor allele) and (IL-9 (T113M) minor allele)) and ((IL-1B (5'UTR T) minor allele) and (VCAM1 (-1594 C) minor allele)))). L2 = (((TNFA (-308 G) major allele) and (VDR (intron G) minor allele)) AND ((IL-4R (I50V) minor allele) or ICAM1 (K56M))).
###end p 56
###begin title 57
Discussion
###end title 57
###begin p 58
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Knight1">[36]</xref>
###xml 289 293 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Bellamy1">[37]</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Smith1">[38]</xref>
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Lard1">[39]</xref>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-International1">[40]</xref>
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-McCusker1">[41]</xref>
###xml 295 298 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The pathogenesis of trachoma, as in many diseases, is related to the complex interplay of the environment, pathogen, epigenetic factors and the host immune response that is intimately related to host genetic susceptibility to disease. Susceptibility to cerebral malaria [36], tuberculosis [37], HIV [38], rheumatoid arthritis [39], multiple sclerosis [40], and Alzheimer disease [41] are among the diseases found to be associated with SNPs in inflammatory genes. To date, there are minimal studies linking polymorphisms in inflammatory genes with the severe end-stage disease of trachoma, TT.
###end p 58
###begin p 59
###xml 586 600 586 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. trachomatis</italic>
###xml 742 746 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Knight1">[36]</xref>
###xml 747 751 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Smith1">[38]</xref>
###xml 586 600 <span type="species:ncbi:813">C. trachomatis</span>
###xml 679 684 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In this study, we focused on TT as a more accurate clinical sign of disease outcome than active disease (TF and/or TI) and, therefore, less susceptible to misclassification and more suitable for genetic studies of susceptibility. For TF and TI, it is not clear which individuals with inflammation will go on to develop sequela or clear the inflammation without progression to disease. Thus, we considered it best not to classify these individuals as cases or controls. TF and TI were controlled for in multivariate logistic regression analysis for these reasons. We also controlled for C. trachomatis infection because other infectious diseases such as malaria, tuberculosis and HIV-1 have been shown to be independently associated with SNPs [36]-[38], although the association of specific SNPs with chlamydiae has not been evaluated.
###end p 59
###begin p 60
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G&gt;A</italic>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Pennica1">[42]</xref>
###xml 392 396 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Aggarwal1">[43]</xref>
###xml 510 514 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Perfettini1">[44]</xref>
###xml 535 543 527 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 601 615 589 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. trachomatis</italic>
###xml 615 619 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-ShemerAvni1">[45]</xref>
###xml 682 696 666 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. trachomatis</italic>
###xml 779 783 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Williams1">[46]</xref>
###xml 956 960 936 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Bobo1">[11]</xref>
###xml 962 966 942 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Faal1">[13]</xref>
###xml 968 972 948 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Skwor1">[14]</xref>
###xml 1085 1089 1061 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Faal1">[13]</xref>
###xml 549 554 <span type="species:ncbi:9606">human</span>
###xml 601 615 <span type="species:ncbi:813">C. trachomatis</span>
###xml 682 696 <span type="species:ncbi:813">C. trachomatis</span>
###xml 727 733 <span type="species:ncbi:10090">murine</span>
We found an association between TT and polymorphisms in two genes that are members of the TNF superfamily: TNFA (-308 G>) and LTA (intron G>A). Both genes are located on chromosome 6, as is the major histocompatibility complex (MHC), and are highly similar structurally and functionally [42]. The cytokines encoded by these two genes bind the same receptor, which is upregulated by IFN-gamma [43]. TNF-alpha is a major proinflammatory cytokine secreted by an array of leucocytes in chlamydial infected tissues [44]. It was first shown in vitro that human recombinant TNF-alpha inhibited the growth of C. trachomatis[45]. Following this finding, the cytotoxic effect of TNF-alpha on C. trachomatis infected cells was shown in a murine model of chlamydial genital tract infections [46]. TNF-alpha mRNA transcripts and protein levels have been reported to be significantly higher in subjects who were infected with chlamydiae than those who were not infected [11], [13], [14]. Conjunctival TNF-alpha mRNA levels have also been found to be positively correlated with duration of infection [13].
###end p 60
###begin p 61
###xml 157 159 157 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GA</italic>
###xml 179 181 179 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</italic>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Natividad2">[20]</xref>
###xml 690 692 690 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GA</italic>
###xml 761 765 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Natividad2">[20]</xref>
###xml 830 832 826 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</italic>
The TNFA (-308) polymorphism, located in the promoter region, has been extensively studied for genetic association with a variety of diseases. We found -308 GA (heterozygous) and AA genotypes to be associated with a decreased odds of TT whereas a previous study found an association with susceptibility to TT [20]. This might be due to geographic and population differences. However, it is not clear if there was any adjustment for infection or active disease status, as in our study. In addition, the p-value cut-off for statistical significance was 0.048, which is not conservative for a population based genetic association study. In the same study, they also found that the TNFA (-308) GA genotype was correlated with increased TNF-alpha protein production [20]. However, this finding depended on only three subjects with the AA genotype. Their p-value by ANOVA was only 0.043, and by Kruskall-Wallis was 0.075.
###end p 61
###begin p 62
###xml 62 76 58 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. trachomatis</italic>
###xml 188 192 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Bobo1">[11]</xref>
###xml 194 198 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Faal1">[13]</xref>
###xml 243 244 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 324 325 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 62 76 <span type="species:ncbi:813">C. trachomatis</span>
Elevated TNF-alpha levels have been considered protective for C. trachomatis infection and essential for resolution of active disease but, it has also been associated with chronic disease [11], [13]. More importantly, the effect of TNFA (-308 G) carried an increased risk of TT if an individual also carried the VDR (intron G), IL-4R (50V), and ICAM-1 (56M) minor allele. However, further quantitative protein studies will be required to characterize the role of this protein and SNP in TT.
###end p 62
###begin p 63
###xml 301 305 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Igietseme1">[47]</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Roan1">[48]</xref>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-AbuelAsrar1">[49]</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Reacher1">[50]</xref>
###xml 438 439 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 539 543 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Natividad2">[20]</xref>
###xml 582 583 582 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 611 612 611 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 657 659 657 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</italic>
###xml 684 686 684 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</italic>
The LTA gene, also known as TNFB, is primarily expressed in lymphocytes and has been associated with regulating CD8+ T lymphocytes. Several animal models of genital chlamydial infection have shown that CD8+ T cells are protective against chlamydial infection and are necessary for infection clearance [47], [48]. In TT cases, elevated CD8+ T lymphocytes have been identified in conjunctival samples [49], [50]. We found that the LTA (252 A) variant was significantly associated with a decreased odds of TT. Interestingly, Natividad et.al. [20] found an association between LTA (252 G) and TT. We found that the A allele decreased the odds of TT, given that GG was our reference while AA homozygosity was their reference.
###end p 63
###begin p 64
###xml 274 278 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Tanaka1">[51]</xref>
###xml 414 418 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Kaifi1">[52]</xref>
###xml 420 424 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Bacon1">[53]</xref>
###xml 518 520 511 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TC</italic>
###xml 557 559 550 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TC</italic>
###xml 612 613 605 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 771 775 764 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Kelly1">[54]</xref>
###xml 776 780 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Perry1">[56]</xref>
###xml 879 883 872 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Igietseme2">[55]</xref>
###xml 946 947 939 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 953 957 946 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Ozaki1">[57]</xref>
###xml 758 764 <span type="species:ncbi:10090">murine</span>
One of the major factors involved in the migration of leukocytes to the foci of infection are a family of adhesion molecules. VCAM-1 is a member of the IgG superfamily that is expressed on endothelial cells and leads to the adhesion of lymphocytes via alpha4beta1 integrins [51]. In peripheral endothelia, especially in the conjunctiva, polymorphonuclear leukocytes act as generators of the inflammation processes [52], [53]. To our knowledge, we are the first to report an association between TT and the VCAM1 (-1594 TC) polymorphism where heterozygosity (TC) decreased the odds of TT [O.R. = 0.47 (0.25-0.86), p-value = 0.015-MLR]. ICAM-1 and VCAM-1 have been found to be significantly elevated in the vasculature after genital chlamydial infection in the murine model [54]-[56]. VCAM-1 has also been associated with a Th1 immune response and clearance of chlamydial infection [55]. Interestingly, VCAM-1 is induced by LTA, and by the LTA (252 A) SNP [57]. Thus, variation in LTA and adhesion molecules may increase homing of T cells to the mucosa, which might play a significant role in clearance and prevention of disease progression to TT.
###end p 64
###begin p 65
###xml 98 112 98 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. trachomatis</italic>
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Shaw1">[58]</xref>
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Roan2">[60]</xref>
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Skwor1">[14]</xref>
###xml 474 478 474 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Modi1">[61]</xref>
###xml 815 816 815 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 826 833 826 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003600-t002">Table 2</xref>
###xml 919 920 919 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 930 937 930 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003600-t004">Table 4</xref>
###xml 1009 1013 1009 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Renauld1">[62]</xref>
###xml 1118 1122 1118 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Holbrook1">[63]</xref>
###xml 1176 1180 1176 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Uyttenhove1">[64]</xref>
###xml 1349 1353 1341 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Grohmann1">[65]</xref>
###xml 1355 1359 1347 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Wu1">[66]</xref>
###xml 1470 1474 1462 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Burton2">[12]</xref>
###xml 1475 1479 1467 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Skwor1">[14]</xref>
###xml 1481 1485 1473 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003600-Holland1">[67]</xref>
###xml 98 112 <span type="species:ncbi:813">C. trachomatis</span>
It is well-documented that cellular-mediated immunity is critical in eliciting protection against C. trachomatis[58]-[60]. We were therefore interested in studying multiple SNP polymorphisms within the Th1/Th2/Th3 cytokine family. In our previous study, we demonstrated that Th1 and some Th2 cytokines were protective against chronic, scarring trachoma [14]. The IL9 gene loci is assigned to chromosome 5q31.1, similar to other Th2 cytokines, including IL-4, IL-5 and IL-13 [61]. On the IL-9 protein, a cytosine at amino acid position 338 in exon 5 is substituted by thymine, resulting in a non-synonymous mutation from a hydrophilic threonine to a hydrophobic methionine at position 113 (T113M). In our study, the IL-9 major allele frequency (T113M) differed significantly between cases (0.96) and controls (0.84, p = 0.001, Table 2), and heterozygosity exhibited protection against TT in our population (O.R. = 0.25, p = 0.004, Table 4). IL-9 is a pleiotropic cytokine produced primarily by Th2 lymphocytes [62]. It has been associated with proliferation and maturation of both lymphoid and myeloid cell progenitors [63] as well as growth factor for activated T lymphocytes [64]. Physiologically, it causes decreased levels of the proinflammatory cytokines TNF-alpha, IL-12p40, and IFN-gamma while increasing the levels of anti-inflammatory IL-10 [65], [66]. The association of elevated IL-10 mRNA expression and protein levels with TS and TT has been well documented [12]-[14], [67], suggesting a plausible biological role for the IL9 polymorphism in disease pathogenesis.
###end p 65
###begin p 66
###xml 362 363 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
###xml 395 396 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</italic>
Logic regression is particularly appropriate for determining multiple interactions among many polymorphisms, and accounts for multiple comparisons. Our results indicate the importance of the effect of interacting gene variants on disease susceptibility. We showed that different combinations of SNPs had a synergistic effect on TT. The combination of TNFA (-308 G) major allele, and VDR (intron G) minor allele, and either IL4R (I50V) minor allele or ICAM1 (K56M) minor allele significantly increased the odds of TT [odds ratio = 13.5 (95% confidence interval 3.3-22), p = 0.001]. Individually, none of these SNPs was statistically associated with TT. SNP interactions that are repeatedly detected might indicate immune pathways that could be contributors to disease pathogenesis, and could be used as markers for individuals at risk for disease progression.
###end p 66
###begin p 67
###xml 147 149 147 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TC</italic>
We confirmed significant associations between TNFA and LTA polymorphisms and TT, and showed for the first time an association between VCAM1 (-1594 TC) and IL9 (T113M) polymorphisms and protection from TT. More importantly, this study indicates that interacting SNPs likely have a synergistic effect on disease. Our findings lay the foundation for selecting additional genes to study that may be in linkage disequilibrium with the SNPs that we found to be associated with TT. In addition, it will now be possible to determine whether dysregulated cytokine and/or chemokine production are associated with the susceptibility variants. These will be important next steps in trachoma research.
###end p 67
###begin title 68
Supporting Information
###end title 68
###begin p 69
Characteristics of Matched Population
###end p 69
###begin p 70
(0.09 MB DOC)
###end p 70
###begin p 71
Click here for additional data file.
###end p 71
###begin p 72
Major Allele Frequencies among 51 SNPs in 36 Inflammatory Genes for Trachomatous Trichiasis (TT) Cases and Controls
###end p 72
###begin p 73
(0.04 MB DOC)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
Genotype Distribution by TT Status Based on Univariate Analysis
###end p 75
###begin p 76
(0.05 MB DOC)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
Multivariate Analysis of Inflammatory Gene SNPs Associated with TT Cases Compared with Controls
###end p 78
###begin p 79
(0.05 MB DOC)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
We would like to thank the villagers of Kapilvastu District, Lumbini Zone, Nepal, for participating in this study. We thank Nicole Santos for excellent technical assistance with the Roche Linear Array assay.
###end p 81
###begin title 82
References
###end title 82
###begin article-title 83
Multiple Chlamydiaceae species in trachoma: implications for disease pathogenesis and control.
###end article-title 83
###begin article-title 84
Global data on visual impairment in the year 2002.
###end article-title 84
###begin article-title 85
The epidemiology of trachoma in central Tanzania.
###end article-title 85
###begin article-title 86
Pathogenesis of Chlamydial Ocular Infections.
###end article-title 86
###begin article-title 87
Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection.
###end article-title 87
###begin article-title 88
Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania.
###end article-title 88
###begin article-title 89
###xml 16 37 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study.
###end article-title 89
###begin article-title 90
###xml 45 66 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community.
###end article-title 90
###begin article-title 91
Mucosal immunity and vaccines.
###end article-title 91
###begin article-title 92
Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma.
###end article-title 92
###begin article-title 93
Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic.
###end article-title 93
###begin article-title 94
Temporal cytokine gene expression patterns in subjects with trachoma identify distinct conjunctival responses associated with infection.
###end article-title 94
###begin article-title 95
Role of secreted conjunctival mucosal cytokine and chemokine proteins in different stages of trachomatous disease.
###end article-title 95
###begin article-title 96
###xml 39 44 <span type="species:ncbi:9606">women</span>
Incidence of trichiasis in a cohort of women with and without scarring.
###end article-title 96
###begin article-title 97
Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid.
###end article-title 97
###begin article-title 98
###xml 68 89 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis-endemic population.
###end article-title 98
###begin article-title 99
Polymorphisms in the IkappaB-alpha promoter region and risk of diseases involving inflammation and fibrosis.
###end article-title 99
###begin article-title 100
Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci.
###end article-title 100
###begin article-title 101
###xml 77 98 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection in Gambians.
###end article-title 101
###begin article-title 102
###xml 96 117 <span type="species:ncbi:813">Chlamydia trachomatis</span>
A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection.
###end article-title 102
###begin article-title 103
A simple system for the assessment of trachoma and its complications.
###end article-title 103
###begin article-title 104
Risk factors for recurrence of postoperative trichiasis: implications for trachoma blindness prevention.
###end article-title 104
###begin article-title 105
Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis.
###end article-title 105
###begin article-title 106
Logic Regression.
###end article-title 106
###begin article-title 107
###xml 36 44 <span type="species:ncbi:9606">children</span>
Risk factors for active trachoma in children and trichiasis in adults: a household survey in Amhara Regional State, Ethiopia.
###end article-title 107
###begin article-title 108
The prevalence of trachomatous trichiasis in Oman (Oman eye study 2005).
###end article-title 108
###begin article-title 109
###xml 30 38 <span type="species:ncbi:9606">patients</span>
Characteristics of trichiasis patients presenting for surgery in rural Ethiopia.
###end article-title 109
###begin article-title 110
Bacterial infection and trachoma in the gambia: a case control study.
###end article-title 110
###begin article-title 111
How reliable is the clinical exam in detecting ocular chlamydial infection?
###end article-title 111
###begin article-title 112
Azithromycin in control of trachoma.
###end article-title 112
###begin article-title 113
###xml 20 41 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
###end article-title 113
###begin article-title 114
The Burden of Trachoma in Ayod County of Southern Sudan.
###end article-title 114
###begin article-title 115
The epidemiology of low vision and blindness associated with trichiasis in southern Sudan.
###end article-title 115
###begin article-title 116
Longitudinal study of trachomatous trichiasis in the Gambia.
###end article-title 116
###begin article-title 117
A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria.
###end article-title 117
###begin article-title 118
Interferon-gamma and host susceptibility to tuberculosis.
###end article-title 118
###begin article-title 119
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.
###end article-title 119
###begin article-title 120
Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis.
###end article-title 120
###begin article-title 121
Risk alleles for multiple sclerosis identified by a genomewide study.
###end article-title 121
###begin article-title 122
Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study.
###end article-title 122
###begin article-title 123
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.
###end article-title 123
###begin article-title 124
###xml 34 39 <span type="species:ncbi:9606">human</span>
Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon.
###end article-title 124
###begin article-title 125
###xml 10 31 10 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia trachomatis</italic>
###xml 10 31 <span type="species:ncbi:813">Chlamydia trachomatis</span>
###xml 115 121 <span type="species:ncbi:10090">murine</span>
Effect of Chlamydia trachomatis infection and subsequent tumor necrosis factor alpha secretion on apoptosis in the murine genital tract.
###end article-title 125
###begin article-title 126
###xml 14 35 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor.
###end article-title 126
###begin article-title 127
###xml 54 60 <span type="species:ncbi:10090">murine</span>
###xml 61 82 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.
###end article-title 127
###begin article-title 128
###xml 12 13 12 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones.
###end article-title 128
###begin article-title 129
###xml 41 62 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Antigen-specific CD8+ T cells respond to Chlamydia trachomatis in the genital mucosa.
###end article-title 129
###begin article-title 130
Immunopathogenesis of conjunctival scarring in trachoma.
###end article-title 130
###begin article-title 131
T cells and trachoma. Their role in cicatricial disease.
###end article-title 131
###begin article-title 132
###xml 75 80 <span type="species:ncbi:9606">human</span>
Morphological aspects of LFA-1/ICAM-1 and VLA4/VCAM-1 adhesion pathways in human lymph nodes.
###end article-title 132
###begin article-title 133
Distinct roles for PECAM-1, ICAM-1, and VCAM-1 in recruitment of neutrophils and eosinophils to the cornea in ocular onchocerciasis (river blindness).
###end article-title 133
###begin article-title 134
Adhesion molecules and relationship to leukocyte levels in allergic eye disease.
###end article-title 134
###begin article-title 135
###xml 138 159 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis.
###end article-title 135
###begin article-title 136
###xml 30 51 <span type="species:ncbi:813">Chlamydia trachomatis</span>
Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae.
###end article-title 136
###begin article-title 137
###xml 87 96 87 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chlamydia</italic>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
Distinct homing pathways direct T lymphocytes to the genital and intestinal mucosae in Chlamydia-infected mice.
###end article-title 137
###begin article-title 138
Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction.
###end article-title 138
###begin article-title 139
Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective.
###end article-title 139
###begin article-title 140
###xml 113 132 <span type="species:ncbi:83560">Chlamydia muridarum</span>
Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection.
###end article-title 140
###begin article-title 141
Monitoring the T cell response to genital tract infection.
###end article-title 141
###begin article-title 142
###xml 29 34 <span type="species:ncbi:9606">human</span>
Regional localization of the human glutaminase (GLS) and interleukin-9 (IL9) genes by in situ hybridization.
###end article-title 142
###begin article-title 143
Interleukin-9.
###end article-title 143
###begin article-title 144
Effect of interleukin-9 on clonogenic maturation and cell-cycle status of fetal and adult hematopoietic progenitors.
###end article-title 144
###begin article-title 145
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity.
###end article-title 145
###begin article-title 146
###xml 14 18 <span type="species:ncbi:10090">mice</span>
IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-alpha, IL-12, and IFN-gamma, and induction of IL-10.
###end article-title 146
###begin article-title 147
###xml 59 67 <span type="species:ncbi:9606">patients</span>
IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis.
###end article-title 147
###begin article-title 148
###xml 106 127 <span type="species:ncbi:813">Chlamydia trachomatis</span>
T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring.
###end article-title 148
###begin p 149
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 149
###begin p 150
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research was supported in part by Public Health Service from the National Institutes of Health, R01 AI059647 (to DD), R01 EY/AI012219 (to DD) and R01 AI059647-1S1 (to DD). The funding agencies/sponsors listed above had no involvement in the design and conduct of study; in the collection, management, analysis or interpretation of the data; or in the preparation, review or approval of the manuscript.
###end p 150

